FDA Inspection
Williams OB/GYN & AssociatesWilliams OB/GYN & Associates – FDA Inspection, Aug 12, 2024
Record Details
This FDA Inspection record concerns Williams OB/GYN & Associates, with an inspection on August 12, 2024, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 721a6999-3478-4127-908d-2e25783d8500
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1246440
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
5- 21 CFR 1271.75(a)(1)Risk factors, clinical evidence
- 21 CFR 1271.50(a)Determination based on screening and testing
- 21 CFR 1271.90(c)Eligibility not required--warning labels
- 21 CFR 1271.60(a)Completion of eligibility determination
- 21 CFR 1271.47(a)Design of procedures to ensure compliance
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Williams OB/GYN & Associates
2| Date | Classification | Office | Project area |
|---|---|---|---|
| May 24, 2021 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| January 20, 2010 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Williams OB/GYN & Associates
- FDA Inspection 1142919 - 2021-05-24
- FDA Inspection 643181 - 2010-01-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.